Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia
Completed · Phase 4
Conditions studied: Pneumonia
In brief
Randomized trial of nursing home residents with pneumonia to assess if intramuscular cefepime is a safe, efficacious, and cost-effective alternative to once daily intramuscular ceftriaxone for the treatment of elderly nursing home residents who develop pneumonia and do not require hospitalization.
Key facts
- Study ID
- NCT00358202
- Run by
- CPL Associates
- People needed
- 69
- Starts
- 2002-03-01
- Expected to finish
- 2006-04-01
- Last updated by the study team
- 2007-10-31
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- CPL Associates,LLC — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.